Noninvasive Multiparametric Imaging of Metastasis-Permissive Microenvironments in a Human Prostate Cancer Xenograft

被引:33
作者
Penet, Marie-France [1 ]
Pathak, Arvind P. [1 ]
Raman, Venu [1 ]
Ballesteros, Paloma [2 ]
Artemov, Dmitri [1 ]
Bhujwalla, Zaver M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Vivo Cellular & Mol Imaging Ctr Program, Baltimore, MD 21205 USA
[2] Univ Nacl Educ Distancia, Lab Organ Synth & Mol Imaging Magnet Resonance, E-28040 Madrid, Spain
关键词
COMBINED MAGNETIC-RESONANCE; RENAL-CELL CARCINOMA; HIGH LACTATE LEVELS; IN-VIVO; EXTRACELLULAR PH; RAT-BRAIN; NUDE-MICE; MICROVESSEL DENSITY; TUMOR ANGIOGENESIS; MALIGNANT ASCITES;
D O I
10.1158/0008-5472.CAN-09-1782
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis continues to be one of the major causes of mortality from prostate cancer. Because human malignant cell lines metastasize more readily from orthotopic sites than from heterotopic sites, to identify metastasis-permissive tumor microenvironments, we used noninvasive imaging to compare the in vivo vascular, metabolic, and physiologic characteristics of a human prostate cancer xenograft implanted orthotopically in the prostate or s.c. in the flank. Hypoxia was detected in these xenografts by placing an enhanced green fluorescence protein optical reporter under the control of a hypoxia response element. A multiparametric analysis of hypoxia, extracellular pH, vascularization, and metabolism provided a characterization of environments that are permissive for metastasis to occur. We found that orthotopic tumors, which metastasized more easily, were characterized by higher vascular volume, permeability, and total choline and a more acidic extracellular pH. Interestingly, metastatic deposits in the lymph nodes as well as cancer cells in ascites fluid were found to be hypoxic, explaining, in part, the refractory nature of metastatic disease. These results also provide the basis for clinically translatable noninvasive imaging markers for predicting metastatic risk in prostate cancer. [Cancer Res 2009;69(22):8822-9]
引用
收藏
页码:8822 / 8829
页数:8
相关论文
共 52 条
[1]   Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model - an MRI study [J].
Abramovitch, R ;
Itzik, A ;
Harel, H ;
Nagler, A ;
Vlodavsky, I ;
Siegal, T .
NEOPLASIA, 2004, 6 (05) :480-489
[2]   Malignant ascites: Past, present, and future [J].
Adam, RA ;
Adam, YG .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (06) :999-1011
[3]  
An ZL, 1998, PROSTATE, V34, P169
[4]   Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts [J].
Bhujwalla, ZM ;
Artemov, D ;
Natarajan, K ;
Ackerstaff, E ;
Solaiyappan, M .
NEOPLASIA, 2001, 3 (02) :143-153
[5]  
Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355
[6]   In vivo quantification of choline compounds in the breast with 1H MR spectroscopy [J].
Bolan, PJ ;
Meisamy, S ;
Baker, EH ;
Lin, J ;
Emory, T ;
Nelson, M ;
Everson, LI ;
Yee, D ;
Garwood, M .
MAGNETIC RESONANCE IN MEDICINE, 2003, 50 (06) :1134-1143
[7]   Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis [J].
Burton, Jeremy B. ;
Priceman, Saul J. ;
Sung, James L. ;
Brakenhielm, Ebba ;
An, Dong Sung ;
Pytowski, Bronislaw ;
Alitalo, Kari ;
Wu, Lily .
CANCER RESEARCH, 2008, 68 (19) :7828-7837
[8]   Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin [J].
Cai, Ke Xia ;
Tse, Lai Ying ;
Leung, Carly ;
Tam, Paul K. H. ;
Xu, Ruian ;
Sham, Mai Har .
CLINICAL CANCER RESEARCH, 2008, 14 (03) :939-949
[9]  
Chen B, 2005, CLIN CANCER RES, V11, P720
[10]  
Dong ZY, 1999, CANCER RES, V59, P872